SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013594-10-000488
Filing Date
2010-03-30
Accepted
2010-03-30 16:26:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 MARCH 30, 2010 nabi13da-033010.htm SC 13D/A 150342
  Complete submission text file 0001013594-10-000488.txt   152515
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 10714184
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 461 FIFTH AVENUE 10TH FLOOR NEW YORK NY 10017
Business Address 461 FIFTH AVENUE 10TH FLOOR NEW YORK NY 10017 (212) 808-3590
DellaCamera Capital Management, LLC (Filed by) CIK: 0001391052 (see all company filings)

IRS No.: 061757281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A